In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...

Pulmonary hypertension is a serious medical condition ... artery smooth muscle cell proliferation and a key signaling pathway that occurs with PAH. "We also demonstrated that recombinant asporin ...

The workshop will train healthcare providers on the HEARTS clinical pathway, including guidance on medication ... “It’s a ...

Corcept is a profitable biotech company with significant potential for growth, focusing on treating Cushing's Syndrome and ...

The menopause affects all women differently—and each person's experience is unique. While some women view menopause as a new ...

High blood pressure, also called hypertension, can often be managed with medication, as well as dietary and lifestyle changes. Some herbs and spices may also help lower blood pressure. Below are ...

Mosliciguat, an inhaled once-daily PH medication, can reduce the resistance against blood flow in lung blood vessels, a Phase ...

Inflammation and genetic mutations can drive cardiovascular complications in patients with myeloproliferative neoplasms, which include disorders such as polycythemia vera, essential thrombocythemia, ...

The FDA cleared DeepWell DTx's software development kit with indications for stress reduction and hypertension.

The following is a summary of “Prevention of Heart Failure in Hypertension – the Role of Coronary Heart Disease Events ...

The European approval comes months after the FDA’s approval of the first-of-its-kind treatment for pulmonary arterial ...

Combining radium-223 with enzalutamide offered a survival benefit in metastatic castration-resistant prostate cancer, but experts questioned its relevance in a shifting treatment landscape.